Latest news
China's WuXi AppTec Surpasses $4.3 Billion in First-Half Revenue, Overtaking Lonza to Target Global CDMO Crown - finance.biggo.comfinance.biggo.com · Sun, 09 Aug 2026 21:05:00 GMTAnalyst Reiterates Buy on Tenaya Therapeutics, Maintains $5 Price Target Amid Pipeline Progress and Extended Cash Runway - TipRanksTipRanks · Sat, 08 Aug 2026 01:07:54 GMT